Condition: Proteinuric Kidney Diseases · Sponsor: Boehringer Ingelheim
This study is open to adults with certain kidney conditions, including secondary focal segmental glomerulosclerosis (sFSGS), treatment-resistant primary minimal change disease (TR-pMCD), Alport Syndrome (AS), and treatment-resistant primary membranous nephropathy (TR-pMN). Adolescents with treatment-resistant primary MCD can also participate in this study. The purpose of this study is to find out whether a medicine called BI 764198 helps people with these kidney conditions. Participants are put into 2 groups randomly, which means by chance. One group takes BI 764198 tablets, and the other group takes placebo tablets. Placebo tablets look like BI 764198 tablets but do not contain any medicine. Participants take a tablet once a day for 20 weeks. All participants also continue their standard medication for their kidney condition during the study. Participants have twice the chance of being placed in the BI 764198 group than in the placebo group. Participants are in the study for about 7 months. During this time, they visit the study site 6 times and have 3 phone calls. Doctors regularly test the protein levels in participants' urine by collecting urine samples. They also check kidney function by taking blood samples. The results are compared between the two groups to see whether the treatment works. The doctors also regularly check participants' health and take note of any unwanted effects.
This description comes directly from the study's public registry record.
Boehringer Ingelheim · 1-800-243-0127 · clintriage.rdg@boehringer-ingelheim.com
Always discuss trial participation with your own doctor first.
| Nephrology Consultants, LLC | Huntsville, Alabama, United States | Recruiting |
| Kidney Disease Medical Group | Glendale, California, United States | Recruiting |
| Amicis Research Center - Balboa | Granada Hills, California, United States | Recruiting |
| Academic Medical Research Institute - Glendale | Los Angeles, California, United States | Recruiting |
| University of California Los Angeles | Los Angeles, California, United States | Not Yet Recruiting |
| Colorado Kidney Care | Denver, Colorado, United States | Recruiting |
| Florida Kidney Physicians - Boca Raton | Boca Raton, Florida, United States | Recruiting |
| Florida Kidney Physicians, LLC - Fort Lauderdale | Fort Lauderdale, Florida, United States | Recruiting |
| Total Research Group, LLC | Miami, Florida, United States | Recruiting |
| CTR Oakwater, LLC | Orlando, Florida, United States | Recruiting |
| Florida Kidney Physicians - Riverview/Brandon | Riverview, Florida, United States | Recruiting |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago, Illinois, United States | Not Yet Recruiting |
+ 149 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07355296